Carcinoma breast stage IV
Information
- Disease name
- Carcinoma breast stage IV
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT02755272 | Active, not recruiting | Phase 2 | A Study of Pembrolizumab With Carboplatin and Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer | May 31, 2016 | May 2026 |
NCT00433095 | Completed | Phase 2 | Vinorelbine (Oral) Plus Trastuzumab for 1st-line Treatment of HER2/Neu Overexpressing Breast Cancer | ||
NCT00669565 | Completed | Phase 2 | Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin to Treat Breast Cancer | July 2008 | August 2010 |
NCT00199212 | Completed | Phase 1 | PS-341 in Combination With Herceptin in Advanced Breast Cancer That Overexpresses HER-2 | October 2003 | December 2007 |
NCT01631552 | Completed | Phase 1/Phase 2 | Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer | December 17, 2012 | August 13, 2020 |
NCT03511781 | Completed | N/A | Palliative Hypofractionated Radiotherapy in Advanced Incurable Breast Cancer | September 2015 | March 2021 |
NCT06281860 | Recruiting | Phase 1 | Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration | November 24, 2023 | February 1, 2026 |
NCT02183805 | Terminated | Phase 2 | Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast Cancer | June 17, 2014 | December 15, 2020 |
NCT01531764 | Terminated | Phase 2 | BIBW 2992 (Afatinib) and Vinorelbine | July 2012 | September 2013 |
NCT02161315 | Unknown status | Steroid Aromatase Inhibitors Versus Progestogens for nSAID-resistanced Late Stage Breast Cancer | April 2014 | December 2016 | |
NCT02140437 | Withdrawn | Phase 2 | Fulvestrant Combined Anastrozole Versus Anastrozole in Luminal A-like Postmenopausal ABC | March 2014 | June 2016 |
NCT01906112 | Withdrawn | Phase 3 | Role of Surgery for the Primary in Patients With Breast Cancer Stage IV. | August 2013 | August 2019 |